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a b s t r a c t 
Analysis of the proteins of the aqueous humor can help to 
elucidate the complex pathogenesis of primary open angle 
glaucoma. Thanks to advances in liquid chromatography tan- 
dem mass spectrometry (LC-MS/MS) it is now possible to 
identify hundreds of proteins in individual aqueous humor 
samples without the need to pool samples. We performed 
a systematic literature search to find publications that per- 
formed LC-MS/MS on aqueous humor samples of glaucoma 
patients and of non-glaucomatous controls. Of the seven 
publications that we found, we obtained the raw data of 
three publications. These three studies used glaucoma pa- 
tients that were clinically similar (i.e. undergoing glaucoma 
filtration surgery) which prompted us to reanalyse and com- 
bine their data. Raw data of each study were analysed sepa- 
rately with the latest version of MaxQuant (version v1.6.11.0). 
Outcome files were exported to Microsoft Excel. Samples be- 
longing to the same patient were averaged to obtain peptide 
expression values per individual. We compared the overlap 
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of identified proteins using the VLOOKUP function of Excel 
and a publicly available Venn diagram software. For the pep- 
tide sequences that can belong to multiple proteins (usually 
of the same protein family), we initially included all possi- 
bly identified proteins. This ensured that we would not miss 
a potential overlap between the studies due to differences in 
identified peptide counts. Next, of those peptides of which 
we compared multiple proteins, only one unique protein was 
included in our analysis i.e. either the protein overlapping 
between studies or in case of no overlap, the protein that had 
the highest identified peptide count. This yielded 639 unique 
proteins detected in aqueous humor of either glaucoma pa- 
tients or non-glaucomatous controls. In our manuscript en- 
titled “The aqueous humor proteome of primary open angle 
glaucoma: An extensive review” [1] , we further analysed this 
dataset. The dataset was exported to Perseus (version 1.6.5.0). 
We removed contaminants and filtered for proteins detected 
with high confidence, i.e. in more than 70% of the samples 
of at least one study. This yielded 248 proteins of which we 
compared the expression in glaucoma patients against con- 
trol patients. Gene ontology enrichment analysis and path- 
way analysis was used to interpret the results. The unfiltered 
dataset reported in this data article and the approach re- 
ported here to reanalyse and combine raw data of different 
studies can be applied by other glaucoma researchers to gain 
more insight in the pathogenesis of glaucoma. 
© 2020 The Author(s). Published by Elsevier Inc. 
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S
 pecifications Table 
Subject Ophthalmology 
Specific subject area Aqueous humor proteome of primary open angle glaucoma 
Type of data Table 
How data were acquired Raw data were obtained from ProteomeXchange, a publicly available 
database and reanalysed with the freely available MaxQuant software 
(Max Planck Institute version v1.6.11.0). During our study, dataset 
PXD004928 was not yet publicly available and we obtained the raw 
data after contacting the authors. Microsoft Excel was used to combine 
the files. Subsequently, we imported the combined dataset in Perseus 
(Max Planck Institute version 1.6.5.0) for filtering and statistical 
analysis. 
Data format Raw 
Analysed 
Filtered 
Parameters for data collection We performed a systematic literature search to find studies that 
investigate the proteome of aqueous humor from patients with 
glaucoma compared to non-glaucomatous controls. We considered only 
studies that included glaucoma patients without other ocular 
comorbidities. This meant that from the 9 proteomic studies we found, 
7 were eligible to obtain the raw data. We managed to obtain the raw 
data of three publications. They used similar glaucoma patients i.e. 
patients undergoing glaucoma filtration surgery, which prompted us to 
reanalyse their raw data and combine the outcome for new statistical 
analysis. 
( continued on next page )2 
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 Subject Ophthalmology 
Description of data collection We reanalysed the raw data of three publications that investigated the 
aqueous humor proteome of primary open angle glaucoma patients 
compared to non-glaucomatous controls, using LC-MS/MS. We 
downloaded the raw data from the depositories and subsequently 
loaded them into the MaxQuant software program (v1.6.11.0) for 
analysis. Analysed data were exported to Microsoft Excel to average 
duplicates and to combine the different studies into 1 protein database. 
This database was imported into Perseus analysis software (v1.6.5.0) to 
filter for proteins with high detection confidence and subsequent 
statistical analysis to compare glaucoma patients with controls. 
Data source location University Eye Clinic Maastricht 
Maastricht 
Netherlands 
Data accessibility RAW data were obtained from ProteomeXchange: 
Dataset 1: “Human aqueous humor of Primary open angle glaucoma 
LC-MS/MS”; PXD007624; 
https://www.ebi.ac.uk/pride/archive/projects/PXD007624 Dataset 2: 
“Comparative shotgun proteomics of aqueous humor for cataract, 
glaucoma and pseudoexfoliation eye disorders”; PXD002623; 
https://www.ebi.ac.uk/pride/archive/projects/PXD002623 
Dataset 3: “Comparative evaluation of the aqueous humor proteome of 
primary angle closure and primary open angle glaucomas and senile 
cataract eyes”; PXD004928; 
https://www.ebi.ac.uk/pride/archive/projects/PXD004928 
Analysed data are included in this article 
Related research article WHG Hubens, RJC Mohren, I Liesenborghs, LMT Eijssen, WD Ramdas, 
CAB Webers, TGMF Gorgels, The aqueous humor proteome of primary 
open angle glaucoma: an extensive review, Exp. Eye Res. 197 (2020) 
108077 
doi: 10.1016/j.exer.2020.108077 
Value of the Data 
• This dataset provides the list of proteins present in the aqueous humor of primary open
angle glaucoma patients and cataract patients and facilitates extraction and quantification of
disease specific differences. 
• This dataset is a rich resource for glaucoma researchers and pharmaceutical companies inter-
ested in unravelling the proteome of primary open angle glaucoma. 
• The dataset facilitates pathway analysis to identify new glaucoma pathways that can be tar-
geted in human or animal studies, with the aim of establishing new biomarkers or new in-
terventions for primary open angle glaucoma. 
• The approach detailed here to regroup, combine and reanalyse publicly available data may
be useful for other studies on data in public databases. 
1. Data Description 
Fig. 1: 
Fig. 1 is a flowchart that visualizes the workflow that we followed in our review on the aque-
ous humor proteome of primary open angle glaucoma patients. In short, a literature search was
performed to find eligible studies. We subsequently tried to obtain the raw data related to these
studies either via publicly available repositories or by attempting to contact the corresponding
author. Three datasets were obtained (see data accessibility table for the respective links). Each
dataset was reanalysed and processed, after which they were combined into 1 dataset for sta-
tistical analysis. 3 
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Fig. 1. Flowchart reporting the workflow to obtain a combined proteomic dataset of glaucomatous aqueous humor. 
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a  File 1: 
File 1 is a description of the patient characteristics. The columns are self-explanatory.
umphrey visual field analyser test results (column J and K) were not available for some pa-
ients as indicated by “NA”. The samples highlighted in red were excluded from our combined
nalysis, because these patients were additionally diagnosed with pseudoexfoliation syndrome
PEX). The remaining controls and glaucoma patients were pooled to form a combined dataset
f which the average age, gender distribution and average eye pressure is provided in columns
-S. Statistical analysis (column T) showed that these parameters were not significantly different
etween the two groups. 
File 2 (general): 
We reanalysed the three datasets with MaxQuant and exported the output files to Microsoft
xcel (file 2). The data are named after the corresponding first authors. These files are consid-
red as raw data, i.e. they are unprocessed and contain several redundant columns. The general
ayout is as follows: possible identified proteins (A), protein with most peptide reads (B), how
any times a peptide was measured (C-E), the protein names (F), gene symbol (G), fasta header
H), peptide read per sample, molecular weight of the protein, peptide identification method,
equence coverage, uncorrected intensity, IBAQ correction intensity, LFQ corrected intensity and
S/MS count. 
For each file, the samples were differently annotated by the authors. An overview is given
elow: 
File 2 dataset 1: Adav. 
This dataset contains 5 control patients (CG065, CG070, CG072, CG075 and CG078) and 5
laucoma patients (G009, G010, G016, G039 and G041). Aqueous humor of each patient was
nalysed in duplo (_A and _B). 
File 2 dataset 2: Kaur . 
This dataset contains 9 control patients and 9 glaucoma patients. Control group was denoted
s Cat and glaucoma group as POAG. It seems this study was performed in two batches. The first4 
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 batch of 4 control and 4 POAG patients was annotated as “long” (Cat 1 U R long, Cat 2 long, Cat
3 long, Cat 4 long, POAG 1 long, POAG 2 long, POAG 3 long ad POAG 4 long) and was performed
in duplo (long1 vs long2). One sample was also analysed a third time (cat 1 U R) presumable to
test a different protocol. The second batch of 5 control (New Cat 1–5) and 5 POAG (New POAG
1–5) were not measured in duplo. 
File 2 dataset 3: Kliuchnikova. 
This dataset contains 11 control patients (k10, k14, k18, k24, k32, k44, k52, k60, k62, k64,
k8) and 7 glaucoma patients (g110, g114, g116, g12, g50, g54, g56). All patients were analysed in
triplo (_1, _2 and _3). 
Processed datasets (file 3 and file 4): 
Protein expressions of duplicate samples were averaged. The averaged intensity, iBAQ inten-
sity and LFQ intensity for each dataset are provided in file 3. This file contains three tabs named
“Adav_duplo removed”, “Kaur_duplo removed” and “Kliu_duplo removed”. Layout and sample 
coding is the same as for file 2. Using VLOOKUP function of Microsoft Excel and Venn diagram
software all reported proteins across studies were matched into a single file (file 4). We present
the proteins (A), majority protein UniProt ID (B), protein name (C), gene name (D), fasta header
(E), in how many samples the protein is identified within each group and study (G-L), the av-
erage LFQ expression in each study (N-P) and showed that after normalization the average LFQ
intensity was the same in each study (column S-U). The normalized LFQ intensity per sam-
ple/study is reported (column W-BP) and the raw LFQ intensities is presented in column BR-DK.
Raw intensities (DR-FK) and iBAQ normalized intensities (FP-HI) are also provided. 
Filtered dataset (file 4) : 
For the purpose of our review [1] , the dataset was further analysed in Perseus. We removed
contaminants, filtered on proteins whose LFQ protein expression was detected in more than 70%
of the samples in at least one study, log-normalized the LFQ intensities and performed multiple
ANOVA to compare glaucoma and control patients. The outcome was again exported to Microsoft
Excel (file 4). The filtered data file consists of the following columns: gene name (A), majority
protein Uniprot ID (B), protein name (C), mean expression in controls (D), in how many control
samples the protein was detected (E), mean expression in glaucoma (F), in how many glaucoma
samples the protein was detected (G), and difference in log transformed protein expression be-
tween glaucoma and controls (H). The uncorrected p-value (I) and the FDR-corrected q-value (J)
are reported. Column L-BE are protein expression values of each individual sample. 
2. Experimental Design, Materials, and Methods 
As depicted in the flowchart ( fig. e1 ), we performed a systematic literature search to find
studies that reported proteomics data from LC-MS/MS studies of glaucoma aqueous humor sam-
ples. Keywords used were “primary open angle glaucoma” and “aqueous humor”. We found
9 LC-MS/MS studies of which 7 studies matched our criteria that other ocular diseases are ab-
sent [2–8] . We attempted to get access to the underlying raw data either via depositories or by
contacting the corresponding authors. We managed to obtain the raw data of three publications
[2–4] (PXD007624, PXD002623 and PXD004928). 
Of two of these publications, the patient characteristics were unfortunately not well defined.
Upon contacting the corresponding authors, they kindly provided us the missing information.
We report the detailed patient characteristics in this manuscript (file 1). Since the inclusion
and exclusion criteria were largely overlapping between the three studies, we decided to pool
the controls and to pool the glaucoma patients for a combined analysis. Patients additionally
diagnosed with pseudoexfoliation syndrome were excluded from this combined dataset. As seen
from columns Q-T, the pooled group of 25 controls and 21 glaucoma patients were comparable
in terms of age, gender distribution and eye pressure. 
The raw data of primary open angle glaucoma patients and controls were reanalyzed using
MAXQuant software (Max Planck Institute; [ 9 , 10 ]). As the raw data varied greatly between the5 
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ptudies, we failed to normalize the data in a pooled reanalysis. Therefore, we decided to reana-
yze each study separately. The following settings were used: 
• Variable modification: Oxidation (M) and Acetylation (protein N-term) 
• Fixed modification: Carbamidomethyl (C) 
• Trypsin digestion 
◦ Max missed cleavage: 2 
• Label free quantification 
◦ Minimum ratio count: 2 
◦ Fast LFQ mode enabled, 
◦ Stabilize large LFQ ratios 
◦ Min number of neighbours: 3; average number of neighbours: 6 
• Peptide identification: 
◦ “from and to”
◦ Advanced identification enabled 
 Second peptides 
 Match between runs 
Output files were exported to Microsoft Excel (file 2). Sample or run duplicates were com-
ined to obtain protein expression values per individual (file 3). We did this according the data
rocessing recommendations of Bijlsma et al [11] . This meant that samples were averaged if
ore than one sample had LFQ expression values. If only one of the duplicate samples had
easured expression values, this sample was considered as the average. For proteins of which
one of the replicates had expression values, the value was set to 0. To combine the datasets,
e extracted the list of majority protein ID’s from each study. In case of multiple majority pro-
ein IDs matching to a peptide sequence, we separated them into different columns. This en-
bled us to check if at least one of the suggested proteins was reported in the other studies,
nsuring the highest amount of overlap between the studies. We identified the overlap via two
ifferent methods i.e. the VLOOKUP function of Microsoft Excel and by using a free Venn di-
gram software (VIB-Ugent; http://bioinformatics.psb.ugent.be/webtools/Venn/ ). After we estab-
ished what proteins had overlapping detection between studies we used the VLOOKUP function
o copy the corresponding expression values of each study, creating our final combined dataset
file 4). For combined analysis in the publication corresponding to this dataset [1] , we used the
FQ intensities of the proteins. LFQ intensities varied greatly between studies (10 0 0 fold differ-
nce) and needed normalization. This was achieved by dividing the LFQ intensity of a protein
y the average LFQ intensity in the respective study and then multiplying by the average LFQ
ntensity across all studies. Researchers can apply other normalization methods on this dataset
or intensity, iBAQ intensity and LFQ intensity. File 4 was subsequently imported to a free analy-
is software (Perseus 1.6.5.0; Max Planck Institute) [12] . Here we filtered for proteins that were
ot considered contaminants and were detected with a high confidence. This meant that within
 study, proteins were detected in at least 70% of either the control patients or the glaucoma
atients. Next, we performed a log-transformation on the normalized LFQ protein expression in-
ensity data and statistically compared the expression of the glaucoma group and the control
roup using the build in multiple comparison ANOVA with FDR-adjusted correction. The out-
ome was exported back to Microsoft Excel (file 5). 
. Ethics Statement 
The current study used data from three previously published datasets on human aqueous
umor proteome and we did not have contact with any of the study participants. All studies
eclared that they adhered to the Declaration of Helsinki and performed the studies on partici-
ants that provided written informed consent. 6 
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